False
By Stephanie Vine
September 4, 2025
Paul Offit, a longtime FDA advisor and prominent figure in vaccine development, sidelined from vaccine committee amid healthcare turmoil in the US.
2 min read
September 4, 2025
Increasing demand for GLP-1s sparks surge in illegal distribution
2 min read
By Stephanie Vine
September 1, 2025
We speak with Adam Pearson, Chief Strategy Officer at Astellas, about the business of being green, success stories in Ireland, and helping local communities.
11 min read
August 28, 2025
The latest developments and success stories in the pharma industry’s continuing journey to a more sustainable future.
1 min read
August 26, 2025
The EMA has maintained its faith in the safe use of titanium dioxide for pharmaceutical applications, but suggests that companies should look into alternatives.
2 min read
By Stephanie Vine
August 13, 2025
FDA looks to streamline reviews of manufacturing facilities in the US.
1 min read
By Rob Coker
August 12, 2025
Industry expert Audrey Greenberg gives the latest update on US pharma, Trump policies, and how pharma supply chains are affected
2 min read
By Heather Purvis
August 12, 2025
Academic medical centers are racing to adapt as political turnover and funding uncertainty threaten the future of cell and gene therapy research.
5 min read
By Stephanie Vine
August 1, 2025
Cases of measles in the US and Europe are reaching record highs.
4 min read
July 31, 2025
Your quick guide to the challenges in microbial contamination control and why surface sampling is paramount.
4 min read
False